AstraZeneca
A global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines. Learn more
Launch date
Employees
Market cap
€221.4b
Enterprise valuation
€245.5b (Public information from Sep 2024)
Share price
$78.58 AZN
Company register number 03674842
Cambridge England (HQ)
Corporate Venture Fund: AstraZeneca Pharmaceutical
No columns specified